Bachem Holding AGBCHMF 96 Receivables Turnover is 2.18 as of Dec. 2025. GuruFocus rates BCHMF with a GF Score™ of 96/100 and a GF Value™ of $97.92 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 839 Biotechnology companies, Bachem Holding AG ranks worse than 69.25% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Bachem Holding AG's Revenue for the
six
months ended in Dec. 2025 was $479.5 Mil. Bachem Holding AG's average Accounts Receivable for the
six
months ended in Dec. 2025 was $219.5 Mil.
Hence, Bachem Holding AG's Receivables Turnover for the
six
months ended in Dec. 2025 was 2.18.
Bachem Holding AG (OTCPK:BCHMF) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Bachem Holding AG Receivables Turnover Related Terms
Bachem Holding AG Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Bachem Holding AG's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BCHMF vs VRTX, REGN, ALNY: Receivables Turnover Comparison
For the Biotechnology subindustry, Bachem Holding AG's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bachem Holding AG Receivables Turnover vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bachem Holding AG's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Bachem Holding AG's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bachem Holding AG (BCHMF) has a Receivables Turnover of 2.18 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Bachem Holding AG and its competitors. According to the industry distribution chart, Bachem Holding AG ranks #581 out of 839 companies in the Biotechnology industry, placing it in the top 69.2%.
Is Bachem Holding AG's Receivables Turnover too high?
Bachem Holding AG's current Receivables Turnover is 2.18. The Biotechnology industry median Receivables Turnover is 5.27. Bachem Holding AG's value of 2.18 is 58.6% below this industry median. Based on the distribution chart, Bachem Holding AG ranks #581 out of 839 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Bachem Holding AG has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bachem Holding AG's Receivables Turnover compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bachem Holding AG ranks #581 out of 839 companies for Receivables Turnover. This places Bachem Holding AG in the lower half of its industry. The industry median Receivables Turnover is 5.27. Bachem Holding AG's value of 2.18 is 58.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.27, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bachem Holding AG's current Receivables Turnover of 2.18 is 58.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Bachem Holding AG and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bachem Holding AG's current Receivables Turnover is 2.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bachem Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Bachem Holding AG (BCHMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $97.92, compared to a current price of $87.34 — trading 10.8% below its estimated fair value. The current Receivables Turnover is 2.18 and 58.6% below the Biotechnology industry median of 5.27. Bachem Holding AG's overall GF Score™ is 96/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Bachem Holding AG (BCHMF), the current Receivables Turnover is 2.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bachem Holding AG (BCHMF) Overvalued in 2026?
Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued.
The current stock price of $87.34 is trading 10.8% below its estimated GF Value™ of $97.92.
GuruFocus considers Bachem Holding AG to be Modestly Undervalued.
Key valuation signals for BCHMF:
Receivables Turnover: 2.18
GF Value™: $97.92 vs. price of $87.34 (10.8% below fair value)
Industry Position: 58.6% below the Biotechnology median (#581 of 839)
No single metric tells the full story. See the BCHMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
96GF Score
Get the complete analysis for BCHMF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BCHMF has been successfully added to your 
